In addition to all the other superb attributes Dr. Gittleson brings to the company, the timing of her appointment will hopefully enable her to participate in the EMA and the following FDA negotiations where her experience of both the Australian industry and government regulatory environments and all her other achievements at CSL will appreciably add to the status of the companies representation and thus their chance of achieving their objectives at these vital negotiations.
In addition to all the other superb attributes Dr. Gittleson...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $94.66M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.0¢ | 10.5¢ | $35.58K | 335.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 375558 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 41673 | 2 |
View Market Depth
| Last trade - 11.01am 18/09/2024 (20 minute delay) ? |
| PER (ASX) Chart |